Pediatrics Doctors in Sierra Vista, AZ Accepting Medicare

7 Pediatrics doctors found. Showing 1 - 7

Dr. Jeffrey H Hill, M.D., PHD Pediatrics Medicare: Medicare Enrolled Practice Location: 5700 E Highway 90 Fl 4, Sierra Vista, AZ 85635 Phone: 520-263-3500

Dr. Kathleen Jane Vedock, DO, FAAP Pediatrics Medicare: Medicare Enrolled Practice Location: 155 Calle Portal, Suite 700, Sierra Vista, AZ 85635 Phone: 520-459-0203    Fax: 520-364-4261

Dr. Ramon Carampatan, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 302 El Camino Real, Suite 11cd, Sierra Vista, AZ 85635 Phone: 520-458-2849    Fax: 520-417-9436

Ms. Joselita M Abeleda, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1590 Paseo San Luis, Ste 102, Sierra Vista, AZ 16354 Phone: 520-459-0203    Fax: 520-364-4261

Dr. Stella C Raposas, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 155 Calle Portal Ste 700, Sierra Vista, AZ 85635 Phone: 520-459-0203    Fax: 520-515-8663

Mr. Steven K Dahlke, MD. PEDIATRICS Pediatrics Medicare: Medicare Enrolled Practice Location: 1590 Paseo San Luis, Suite 102, Sierra Vista, AZ 85635 Phone: 520-459-0203    Fax: 520-364-4261

Rita Kilgore, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 155 Calle Portal Ste 700, Sierra Vista, AZ 85635 Phone: 520-459-0203    Fax: 520-364-4261

News Archive

AIBioTech receives new government contract worth $21 million

American International Biotechnology Services (AIBioTech), a division of Bostwick Laboratories, Richmond, VA, today announced that it is one of four contractors awarded a new government contract valued at approximately $21 million. AIBioTech provides integrated research and development sciences and clinical testing services to physicians and life sciences investigators in biotechnology and pharmaceutical companies, academic institutions, and government agencies. The new contract will be funded in phases, with the first AIBioTech phase valued at nearly $3 million. AIBioTech has assembled a consortium of seven leading technology and biotechnology companies who are poised to meet all of the anticipated scientific objectives.

FDA panel rejects new pancreatic enzyme replacement drug

Eli Lilly & Co did not win the support of the U.S. advisory panel on Wednesday for its one-of-its kind drug not made from pig enzymes to help certain pancreatic patients digest food. A Food and Drug Administration panel of outside experts in a 7-4 vote said they were not convinced the experimental medicine, known chemically as liprotamase, worked well enough for patients to absorb enough needed nutrients. One member of the panel abstained.

Gay men plan blood donation protest

Gay men plan to try to donate blood Friday in protest to a 1977 policy that bans them from doing so. Also, gay health care rights have changed due to a Supreme Court ruling.

Results of Phase I ThermoDox dose escalation trial to be discussed in a press conference

Celsion Corporation today announced that Dr. Ronnie T.P. Poon from the University of Hong Kong and lead principal investigator for the Asia Pacific region of the Phase I ThermoDox dose escalation trial will hold a press conference on Thursday, April 15, 2010 at 10:30 AM HKT (Wednesday, April 14, 2010 10:30 PM ET) to discuss the long-term follow-up of patients treated from April 2006 to December 2006.

Read more Medical News

› Verified 8 days ago